roche免疫產品原料簡介

1、免疫產品簡介免疫產品簡介picture placeholder抗體抗體銷量最好的抗體：CKMB、DD、Ferr、Insulin、E2。Roche單抗為凍干品，建議用0.9%的生理鹽水溶解，溶解濃度為10mg/ml。溶解液的儲存條件： 1 周 (+2 to +8C), 12 周 (-25 to -15C). 請避免反復凍融?？贵w抗體腫瘤：項目項目抗體抗體批號批號備注備注CEAMABTU2 IgG MABM-TU3 IgG 11 353 713 103 10 777 498 103 鼠源單抗凍干AFPMABM-LJ738 IgG MABM-TU11 IgG 11 492 101 103 11 49

2、2 080 103 鼠源單抗凍干FerrMABM-3.170 IgG MABM-4.184 IgG 11 547 089 103 11 547 119 103 鼠源單抗凍干抗體抗體內分泌：項目項目抗體抗體批號批號備注備注LHMABM-11412 IgG MABM-2.406 IgG 11 547 925103 11 547 038103 鼠源單抗凍干FSHMABM-1.303 IgG MABM-W3 IgG 11 493 540103 11 493 531103 鼠源單抗凍干HCGMABM-INN22 IgG MABM-INN2 IgG 11 812 564103 03 116 263103

3、鼠源單抗凍干PRLMABM-C4E4 IgG MABM-H12G10 IgG 11 458 701103 11 027 689103 鼠源單抗凍干E2PAKK IgG 05 344 255 103兔源多抗液體抗體抗體甲功：項目項目抗體抗體批號批號備注備注TSH MABM-1.20 IgG MABM-A8 IgG 10 767 7781 03 11 367 978 103 鼠源單抗凍干T3PABS IgG 10 907 332 103 羊源多抗凍干T4PABS IgG 10 767 794 103 羊源多抗凍干抗體抗體其他：項目項目抗體抗體批號批號備注備注Insulin MABM-ST3 IgG

4、 MABM-BM1 IgG 12 208 750 103 12 208 725 103 鼠源單抗凍干CK-MB MABM-7.4.5 IgG MABM-6.12.47 IgG11 719 815 103 11 719 823 103 鼠源單抗凍干D-DimerMABM-1.2.57 IgG MABM-2.1.16 IgG12 156 903 103 12 045 206 103 鼠源單抗凍干IgEMABM-323 IgG MABM-7H8 IgG 11 543 393 103 11 988 204 103 鼠源單抗凍干CRPPABS IgG 11 888 714 103羊源多抗液體酶和底物酶和

5、底物ALP底物項目項目抗體抗體批號批號備注備注ALPAlkaline Phosphatase, EIA Grade10 556 602 103液體酶活3000u/mgALPAlkaline Phosphatase, recombinant, highly active03 137 031 103液體，酶活7000u/mg糖含量20-30%ALPAlkaline Phosphatase, recombinant, highlyactive, carbohydrate reduce03 535 452 103液體，酶活7000u/mg近天然，糖含量5-10%項目項目抗體抗體批號批號備注備注pNPP

6、4-Nitrophenyl Phosphate10 004 847 103結晶粉末BCIP5-Bromo-4-chloro-3-indolyl-phosphate10 760 978 103結晶粉末酶和底物酶和底物POD底物項目項目抗體抗體批號批號備注備注PODPeroxidase (POD), EIA Grade10 815 462 103凍干酶活225u/mgPODPeroxidase (POD), Grade I10 121 606 103凍干酶活250u/mgPODPeroxidase (POD), Grade II11 378 783 103凍干酶活200u/mgPoly PODPo

7、ly POD, EIA Grade11 578 545 103凍干酶活600u/mg項目項目抗體抗體批號批號備注備注TMB3,3,5,5-Tetramethylbenzidine10 203 700 103結晶粉末放大系統(tǒng)放大系統(tǒng)名稱名稱英文名稱英文名稱批號批號備注備注鏈霉親和素 Streptavidin,recombinant11 520 679 103凍干生物素D-Biotin-N-hydroxysuccinimide ester10 734 250 103白色干粉，短鏈生物素D-Biotinoyl-aminocaproic acid-N-hydroxysuccinimide ester1

8、1 003 933 103白色干粉，長鏈鏈霉素包被磁珠Streptavidin Magnetic Particles11 636 502 103懸濁液磁珠直徑2um左右裸珠干擾消除蛋白干擾消除蛋白非特異性干擾非特異性干擾消除蛋白非特異性干擾消除蛋白Bovine IgGBovine IgG PABB-IgG (DE)Cat. No. 11293621 Interference reduction in assay system working with polyclonal bovine IgG through blocking of e.g. antibody solid phase inte

9、rference Basic interference elimination. Specials: IgG fraction from bovine plasma, purified by DE chromatography with 5 % aggregated IgG 5 % aggregated IgGBSA VBSA VCat. No. 10738328Cat. No. 10738328 Saturation of unoccupied binding sites on the solid phase Basic interference elimination. Specials:

10、 Contains no detectable IgGsSheep IgGSheep IgG PABS-IgG (DE)Cat. No. 10717606 Interference reduction in assay system working with polyclonal sheep IgG through blocking of e.g. antibody solid phase interference Basic interference elimination.Rabbit IgGRabbit IgG PABK-IgG (DE)Cat. No. 10912280 Interfe

11、rence reduction in assay system working with polyclonal rabbit IgG through blocking of e.g. antibody solid phase interference Basic interference elimination.非特異性干擾消除蛋白非特異性干擾消除蛋白BPLA I + IVBPLA I + IVBovine Plasma AlbuminCat. Nos. 1172 6536 1172 6544 0353 5240 Avoidance of non-specific adsorption or

12、antibody interactions for more complex applications with higher demands on sensitivity. Specials: High purity plus pH 4.5 treatmentType I: Type I: purity HPLC 95 %, low content of steroids, lipids and haptens Type IVType IV: purity HPLC 95 %, Type IV NEW !: Type IV NEW !: purity HPLC 95 %, Protease-

13、free ! 2 more production steps compared to old version.Poly BSA I + IIPoly BSA I + IICat. Nos.11866737 + 11816438Due to their own polyvalence they show optimal protection against polyvalent interference (e.g. in infectious disease assays). The negative charge also avoids hydrophobic interactions.Spe

14、cials: Very efficient background signal reduction.Type I - acetylated; diameter 30 nmType II succinylated; diameter 40 nm It is recommended to combine a mono- and a polyvalent reagent !The total amount of non specific IEP is recommended to be at 2-5%.特異性干擾特異性干擾-MAK33 -MAK33 家族家族單體單體 IEPsNote: The us

15、e of a framework-specific IEP is covered by Roche patent. .MAK33 IgG (lyo) MAK33 IgG (lyo) Cat. No 1200 941 - monoclonal IgG1 antibody with defined specificity - for test formulations working with intact IgG1intact IgG1 - mainly for elimination of monomericmonomeric and specific interferenceIEP-Fram

16、eworkIEP-FrameworkCat. No. 03369846 - for elimination of monomeric and highly specific monomeric and highly specific Interference against the framework regions - caused by highly specific and mostly Mab-therapy-induced HAMAS - developed by comparing the amino acid-sequences of different assay antibo

17、dies - use identical immunoreactive amino acid sequences in - use identical immunoreactive amino acid sequences in the framework regions of the interference eliminating the framework regions of the interference eliminating reagent as in the test antibodies. reagent as in the test antibodies. - recom

18、mended for tumor marker, thyroid and cardiac assays.tumor marker, thyroid and cardiac assays.特異性干擾特異性干擾-MAK33 -MAK33 家族家族多聚體多聚體IEPs Note: The use of polymerized IEPs is covered by Roche patent. .MAK33-IgG1/IgG1 Poly MAK33-IgG1/IgG1 Poly (liquid) (liquid) Cat. No 1939 661Cat. No 1939 661 polymerized

19、version of MAK33 (DSS linker chemistry) for test formulations working with intact IgG1intact IgG1 higher efficiency concerning HAMA interference type 1 (spontaneous HAMAs) mainly for elimination of polymericpolymeric and more unspecific interference.MAK33-IgG1/Fab1 Poly MAK33-IgG1/Fab1 Poly (lyo) (l

20、yo) Cat. No 1368 338Cat. No 1368 338 recommended for test systems working with Fab conjugatesFab conjugates comparable characteristics as the a.m. MAK33-IgG/IgG1 poly in addition it covers Fab Neo-epitopescovers Fab Neo-epitopes mainly for elimination of polymericpolymeric and more unspecific interference.Poly MAK IgG2b/Fab2a Poly MAK IgG2b/Fab2a (lyo) Cat. No 1355 (lyo) Cat. No 1355 830830 recommended for test systems working with IgG 2a and/or 2bIgG 2a and/or 2b mainly for elimination of polymericpolymeric and more unspecific interference